Neurocrine Biosciences Stock Overlap Studies Triple Exponential Moving Average
| NBIX Stock | USD 138.64 1.95 1.43% |
| Symbol |
Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. Neurocrine Biosciences Triple Exponential Moving Average indicator shows smoothing effect of Neurocrine Biosciences price series composite of a single exponential moving average, a double exponential moving average and a triple exponential moving average.
Neurocrine Biosciences Technical Analysis Modules
Most technical analysis of Neurocrine Biosciences help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Neurocrine from various momentum indicators to cycle indicators. When you analyze Neurocrine charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Neurocrine Biosciences Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Neurocrine Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Neurocrine Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Neurocrine Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Neurocrine Biosciences's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Neurocrine Biosciences's intrinsic value. In addition to deriving basic predictive indicators for Neurocrine Biosciences, we also check how macroeconomic factors affect Neurocrine Biosciences price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2021 | 2022 | 2023 | 2024 (projected) | Days Sales Outstanding | 59.73 | 85.81 | 84.97 | 89.22 | PTB Ratio | 5.86 | 6.7 | 5.77 | 6.13 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Additional Tools for Neurocrine Stock Analysis
When running Neurocrine Biosciences' price analysis, check to measure Neurocrine Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neurocrine Biosciences is operating at the current time. Most of Neurocrine Biosciences' value examination focuses on studying past and present price action to predict the probability of Neurocrine Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neurocrine Biosciences' price. Additionally, you may evaluate how the addition of Neurocrine Biosciences to your portfolios can decrease your overall portfolio volatility.